Table 2.
List of the identified main actors of improving access to anti-cancer medications in Iran and their category
| No | Abbreviations | Full name | Category |
|---|---|---|---|
| 1 | Gov | Government | Public–domestic |
| 2 | Parl | Parliament | Public–domestic |
| 3 | MoIMT | Ministry of Industry, Mine and Trade | Public–domestic |
| 4 | DotMoHME | Ministry of Health and Medical Education, Deputy of treatment in the MoHME | Public–domestic |
| 5 | DodMoHME | Ministry of Health and Medical Education, Deputy of development in the MoHME | Public–domestic |
| 6 | DoeMoHME | Ministry of Health and Medical Education, Deputy of education in the MoHME | Public–domestic |
| 7 | DorMoHME | Ministry of Health and Medical Education, Deputy of research in the MoHME | Public–domestic |
| 8 | DohMoHME | Ministry of Health and Medical Education, Deputy of health in the MoHME | Public–domestic |
| 9 | SCI | Supreme Council of Insurance | Public–domestic |
| 10 | BI | Basic insurance | Public–domestic |
| 11 | SI | Supplementary insurance | Private–domestic |
| 12 | SubMoEFA | Ministry of Economic and Finance Affairs-subsidy | Public–domestic |
| 13 | TaxMoEFA | Ministry of Economic and Finance Affairs-tax | Public–domestic |
| 14 | CusMoEFA | Ministry of Economic and Finance Affairs-customs | Public–domestic |
| 15 | UOMS | Universities of medical sciences | Public–domestic |
| 16 | SPA | Scientific–professional associations | Public–domestic |
| 17 | Phys | Physicians | Private–domestic |
| 18 | Pharm | Pharmacies | Private–domestic |
| 19 | PharmDC | Pharmaceutical distributions companies | Private–domestic |
| 20 | Pat | Patients | Private–domestic |
| 21 | Pats’F | Patients’ family | Private–domestic |
| 22 | PharS | Pharmaceutical syndicates | Private–domestic |
| 23 | PharIC | Pharmaceutical Importers companies | Public–domestic |
| 24 | PharMC | Pharmaceutical manufacturing companies | Public–domestic |
| 25 | BM | Black market | Private–domestic |
| 26 | ChC | Chemotherapy centres | Public&private–domestic |
| 27 | Hos | Hospitals | Public&private–domestic |
| 28 | SM | Social media | Private–domestic |
| 29 | ICB | Iran Central Bank | Public–domestic |
| 30 | FpharC | Foreign pharmaceutical companies | Foreign |
| 31 | OFC | Other foreign companies | Foreign |
| 32 | GDS | Global drug shortages | Foreign |
| 33 | HMcParl | Health and medical commission of the parliament | Public–domestic |
| 34 | CC | Competition council | Public–domestic |
| 35 | IPoHS | Influential people outside of health sector | Private–domestic |
| 36 | RC | Red Crescent | Public-domestic |
| 37 | LEA | Law enforcement agencies | Public–domestic |
| 38 | VPoSTaKBE | Vice President of Science, Technology and Knowelage-based Economy | Public–domestic |
| 39 | VCF | Venture capital funds | Private–domestic |
| 40 | BBS | Banks and banking system | Public&private–domestic |
| 41 | IFDA | Iran Food and Drug Administration | Public–domestic |
| 42 | NGOs | NGOs | Private-domestic |
| 43 | CPPO | Consumers and Producers Protection Organization | Public–domestic |
| 44 | ICCIMA | Iran Chamber of Commerce | Public–domestic |
| 45 | AoMS | Academy of Medical Sciences | Public–domestic |